Health ❯ Pharmacology

Drug Development

Clinical Trials Therapeutics Combination Therapy Repurposing Drugs Cancer Drugs Drug Repurposing ATI2341 NSAIDs FDA Approval Investigational Drugs

Lancet Trial Finds Semaglutide Cuts Heavy Drinking in Adults With Alcohol Use Disorder

The small, six-month trial signals a potential new role for GLP-1 drugs in treating alcohol dependence.

NIH Identifies DFNZ, a Nitazene Opioid That Eased Pain in Rats Without Breathing Risks

Polilaminina Enters Regulated Testing as Lead Researcher Moves to Correct Preprint

Tirzepatide Cuts Alcohol Drinking and Relapse-Like Behavior in Rodent Study

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

New Study Finds UK Nitazene Deaths Likely Undercounted by Up to a Third

Asundexian Cuts Recurrent Stroke 26% Without More Major Bleeding in Phase III

CXCR4 Circadian Checkpoint Puts Neutrophils in Night Mode, Reducing Cardiac Injury in Mice

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Low-Dose Colchicine Lowers Heart Attack and Stroke Risk in Heart Disease, Cochrane Review Finds

New Review Positions Camelid Nanobodies as a Promising Path for Brain Therapies

Computational Screen Identifies Thiorphan for Spinal Cord Injury With Strong Preclinical Gains

Nature Study Shows Intracellular GPCR Targeting Can Direct Signaling

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Pemafibrate–Telmisartan Combo Cuts Liver Fat in Preclinical MASLD Study

Chlorate Boosts Antibiotics 10,000-Fold Against Pseudomonas in Lab Study

Study Pinpoints EP2 Receptor in Schwann Cells as Target for Pain Relief Without Blocking Inflammation

Elinzanetant Cuts Hot Flashes in Yearlong Phase 3 Study

Anvisa Approves Dayvigo (Lemborexant) for Adult Insomnia in Brazil

CDC Journal Review Presses U.S. to Treat Chagas as Endemic